Mismatch Repair Cancer Syndrome

Types of Mismatch Repair Cancer Syndrome

1. PMS2-associated CMMRD
   Pathogenic variants in the PMS2 gene account for over half of CMMRD cases. PMS2 encodes a protein critical for correcting small insertion–deletion loops; loss leads to severe? genomic instability and early-onset? tumors. medlineplus.gov

2. MSH6-associated CMMRD
   Approximately 20% of patients carry biallelic MSH6 mutations. MSH6 partners with MSH2 to recognize base–base mismatches; its deficiency predisposes predominantly to hematologic and brain cancers in childhood. medlineplus.gov

3. MLH1-associated CMMRD
   Biallelic MLH1 variants underlie a smaller subset of cases. MLH1 forms a complex with PMS2 to execute repair; its loss yields early colorectal polyposis and high-grade gliomas. medlineplus.gov

4. MSH2-associated CMMRD
   Mutations in MSH2 comprise the remaining cases. As a key mismatch sensor, MSH2 deficiency presents similarly to MLH1-CMMRD but may also involve additional extracolonic tumors. medlineplus.gov

Causes

1. Germline MLH1 Mutation
   An inherited change in both copies of the MLH1 gene impairs DNA repair, driving early tumor? formation. medlineplus.gov

2. Germline MSH2 Mutation
   Biallelic defects in MSH2 prevent mismatch recognition, leading to accumulation of replication errors and cancer. medlineplus.gov

3. Germline MSH6 Mutation
   Dual MSH6 variants weaken repair of single-base mismatches, predisposing to lymphomas and gliomas. medlineplus.gov

4. Germline PMS2 Mutation
   Homozygous PMS2 mutations eliminate repair of insertion–deletion loops, causing early colorectal polyp growth. medlineplus.gov

5. Compound Heterozygosity
   Two different pathogenic variants in the same MMR gene (one from each parent) compromise protein function. medlineplus.gov

6. Splice-Site Variants
   Mutations disrupting normal RNA splicing of MMR genes yield truncated, nonfunctional proteins. medlineplus.gov

7. Nonsense Mutations
   Premature stop codons in MMR genes generate truncated proteins lacking repair domains. medlineplus.gov

8. Frameshift Mutations
   Insertions or deletions shift the reading frame, producing aberrant MMR proteins. medlineplus.gov

9. Large Genomic Deletions
   Loss of entire exons or whole MMR genes abolishes repair capacity. medlineplus.gov

10. Missense Variants
    Single amino-acid changes destabilize MMR proteins or disrupt key interactions. medlineplus.gov

11. Founder Mutations
    Population-specific variants (e.g., in Quebec’s Nunavik) cause “attenuated” CMMRD with later-onset cancers. medlineplus.gov

12. Parental Carrier Status
    When both parents carry a single MMR gene variant (Lynch syndrome), each child has a 25% chance of CMMRD. medlineplus.gov

13. Consanguinity
    Related parents increase the probability of inheriting identical pathogenic MMR gene copies. medlineplus.gov

14. EPCAM Deletions
    Rare deletions upstream of MSH2 lead to its epigenetic silencing, mimicking biallelic loss. medlineplus.gov

15. Somatic Second Hits
    Inherited monoallelic carriers may acquire a second somatic mutation, transitioning to full CMMRD in a specific tissue. medlineplus.gov

16. Epigenetic Silencing
    Promoter hypermethylation of MLH1 in germ cells can act like a mutation, reducing gene expression. medlineplus.gov

17. Mosaicism
    Postzygotic MMR gene mutations in early embryogenesis yield mosaic CMMRD, with variable tumor risk. medlineplus.gov

18. Copy-Number Variations
    Gene duplications or losses affecting MMR loci disrupt normal protein dosage?. medlineplus.gov

19. Functional Hypomorphic Variants
    Partial‐function mutations allow some repair but still raise cancer risk. medlineplus.gov

20. Unknown Modifier Genes
    Other genetic? factors may influence CMMRD presentation and age of onset. medlineplus.gov

Symptoms

1. Multiple Colorectal Polyps
   Dozens of benign growths in the large intestine appear often before age 10. medlineplus.gov

2. Early-Onset Colorectal Cancer
   Malignant transformation of polyps leads to colon? or rectal cancer in childhood or adolescence. medlineplus.gov

3. High-Grade Gliomas
   Aggressive brain tumors arise, causing headaches, seizures, or focal neurologic deficits. medlineplus.gov

4. Glioblastoma Multiforme
   A specific, highly malignant glioma subtype leads to rapid neurologic decline. medlineplus.gov

5. Acute? Lymphoblastic Leukemia? (ALL)
   T-cell or B-cell ALL presents with fatigue?, bruising?, and bone pain?. medlineplus.gov

6. Non-Hodgkin Lymphoma?
   Swollen lymph nodes?, fever?, and weight loss? indicate lymphoma in children. medlineplus.gov

7. Small-Intestinal Cancer
   Abdominal pain?, obstruction, or bleeding may signal tumors in the small bowel. medlineplus.gov

8. Urinary Tract Tumors
   Hematuria? and pain? can occur with bladder? or ureteral cancers in teens. medlineplus.gov

9. Endometrial Cancer
   In adolescent girls, abnormal uterine bleeding may reflect early endometrial carcinoma?. medlineplus.gov

10. Ovarian Tumors
    Pelvic pain? or mass effect may indicate ovarian cancer in teenage girls. medlineplus.gov

11. Sarcomas
    Bone or connective tissue tumors present with localized? pain or swelling?. medlineplus.gov

12. Café-au-Lait Spots
    Multiple light-brown skin patches mimic neurofibromatosis type 1. medlineplus.gov

13. Hypopigmented Macules
    Lighter skin patches often accompany café-au-lait spots. medlineplus.gov

14. Developmental Venous Anomalies
    Venous malformations in the brain appear on MRI? without symptoms. medlineplus.gov

15. Growth Retardation
    Chronic illness and multiple cancers impair normal growth. medlineplus.gov

16. Anemia
    Blood loss from polyps or marrow infiltration causes fatigue and pallor. medlineplus.gov

17. Weight Loss
    Cancer-related metabolic changes lead to unintentional weight loss. medlineplus.gov

18. Neurologic Deficits
    Seizures, vision changes, or motor weakness accompany brain tumors. medlineplus.gov

19. Abdominal Pain
    Obstruction or tumor growth in the GI tract triggers crampy pain. medlineplus.gov

20. Bleeding
    GI bleeding from polyps or tumors leads to melena or hematochezia. medlineplus.gov

Diagnostic Tests

Physical Exam

1. General Inspection
   Look for café-au-lait spots, skin hypopigmentation, and growth milestones. medlineplus.gov

2. Abdominal Palpation
   Assess for masses or tenderness from intestinal tumors. medlineplus.gov

3. Neurologic Examination
   Evaluate cranial nerves, motor strength, and reflexes for brain tumor signs. medlineplus.gov

4. Lymph Node Palpation
   Check for lymphadenopathy suggestive of lymphoma. medlineplus.gov

5. Skin Examination
   Document café-au-lait and hypopigmented macules. medlineplus.gov

6. Growth Assessment
   Measure height and weight for growth retardation. medlineplus.gov

7. Rectal Exam
   Detect lower GI masses or bleeding. medlineplus.gov

8. Neurologic Fundoscopy
   Evaluate for papilledema in intracranial hypertension. medlineplus.gov

Manual Tests

9. Digital Rectal Examination
   Palpate rectal polyps or masses. medlineplus.gov

10. Neurologic Sensation Testing
    Assess for focal deficits around brain lesions. medlineplus.gov

11. Gait Analysis
    Observe coordination issues from cerebellar tumors. medlineplus.gov

12. Muscle Strength Testing
    Check for hemiparesis from glioma compression. medlineplus.gov

13. Abdominal Percussion
    Identify organomegaly or fluid accumulation. medlineplus.gov

14. Palpation of Lymphatic Chains
    Detect lymphoma involvement. medlineplus.gov

15. Breast and Pelvic Manual Exam
    Screen for early genital tract tumors in adolescents. medlineplus.gov

16. Muscle Tone Assessment
    Identify spasticity from CNS involvement. medlineplus.gov

Lab and Pathological Tests

17. Complete Blood Count (CBC)
    Detect anemia, leukocytosis, or blasts in leukemia. medlineplus.gov

18. Serum Lactate Dehydrogenase (LDH)
    Elevated in lymphoma and other malignancies. medlineplus.gov

19. CEA and CA 19-9
    Tumor markers for colorectal cancer surveillance. medlineplus.gov

20. AFP and Beta-hCG
    Screen for germ cell tumors in CMMRD. medlineplus.gov

21. Bone Marrow Biopsy
    Confirm leukemia subtype and marrow infiltration. medlineplus.gov

22. Lymph Node Biopsy
    Pathologic diagnosis of lymphoma. medlineplus.gov

23. Polyp Histology
    Determine dysplasia or carcinoma in colorectal polyps. medlineplus.gov

24. Immunohistochemistry for MMR Proteins
    Loss of staining for MLH1, MSH2, MSH6, or PMS2 in tumors indicates MMR deficiency. medlineplus.gov

Electrodiagnostic Tests

25. EEG
    Evaluate seizure focus related to brain tumors. medlineplus.gov

26. EMG/Nerve Conduction
    Assess peripheral neuropathy from chemotherapy. medlineplus.gov

27. Somatosensory Evoked Potentials
    Monitor spinal cord function if intramedullary tumors are suspected. medlineplus.gov

28. Visual Evoked Potentials
    Detect optic pathway involvement by tumor. medlineplus.gov

29. Brainstem Auditory Evoked Responses
    Screen for brainstem compression. medlineplus.gov

30. Motor Evoked Potentials
    Evaluate corticospinal tract integrity. medlineplus.gov

31. Electrocardiogram (ECG)
    Baseline before chemotherapy. medlineplus.gov

32. Holter Monitor
    Long-term cardiac rhythm monitoring during treatment. medlineplus.gov

Imaging Tests

33. MRI Brain with Contrast
    Gold standard for detecting gliomas and developmental venous anomalies. medlineplus.gov

34. CT Abdomen and Pelvis
    Identify colorectal masses and metastatic disease. medlineplus.gov

35. Colonoscopy
    Direct visualization and removal of polyps. medlineplus.gov

36. Capsule Endoscopy
    Screen small intestine for polyps or tumors. medlineplus.gov

37. MRI Spine
    Detect leptomeningeal spread of CNS tumors. medlineplus.gov

38. Ultrasound Pelvis
    Screen for ovarian and uterine tumors in adolescents. medlineplus.gov

39. PET–CT
    Assess metabolic activity and staging of malignancies. medlineplus.gov

40. Chest X-Ray/CT
    Evaluate for pulmonary metastases. medlineplus.gov

Non-Pharmacological Treatments

Physiotherapy and Electrotherapy Therapies 

1. Manual therapy
   Manual therapy involves hands-on techniques to mobilize joints and soft tissues. It can relieve pain, improve mobility, and reduce muscle stiffness after cancer surgery or during recovery.

2. Myofascial release therapy
   This therapy reduces tightness and pain in the connective tissue, helping people improve movement and reduce discomfort, especially after abdominal surgeries.

3. Lymphatic drainage massage
   Used to reduce swelling, especially in patients who have had lymph nodes removed. It helps promote lymph fluid movement and reduce pain.

4. Neuromuscular electrical stimulation (NMES)
   NMES uses electrical currents to stimulate weak muscles, helping rebuild strength, particularly after long hospital stays.

5. Transcutaneous electrical nerve stimulation (TENS)
   TENS relieves pain through electrical impulses, blocking pain signals to the brain and promoting natural painkillers called endorphins.

6. Ultrasound therapy
   Ultrasound waves help promote tissue healing and reduce scar tissue formation, supporting recovery after cancer-related surgeries.

7. Cryotherapy (cold therapy)
   Reduces inflammation, swelling, and pain, especially in joint areas affected during cancer treatments.

8. Heat therapy
   Helps relax muscles, improve blood flow, and reduce stiffness.

9. Balance and gait training
   Focuses on improving stability and preventing falls, especially after chemotherapy, which can affect balance.

10. Breathing exercises
    Helps improve lung function and reduce stress, especially important after abdominal or thoracic surgeries.

11. Pelvic floor rehabilitation
    Strengthens pelvic muscles, which may weaken after certain surgeries or treatments affecting the pelvic area.

12. Scar tissue mobilization
    Helps break down excessive scar tissue and improve skin flexibility.

13. Postural correction therapy
    Improves spinal alignment and prevents musculoskeletal pain.

14. Hydrotherapy
    Water-based exercises reduce joint stress and improve mobility, useful for patients with pain or weakness.

15. Biofeedback therapy
    Teaches control of certain body functions (like muscle tension) to reduce pain and improve function.

Exercise Therapies

1. Aerobic exercise
   Includes walking, cycling, or swimming to improve cardiovascular health and reduce cancer-related fatigue.

2. Resistance training
   Uses weights or bands to improve muscle strength, counteracting muscle loss from cancer treatments.

3. Flexibility exercises
   Stretching routines enhance range of motion and reduce stiffness.

Mind-Body Therapies

1. Yoga
   Combines physical postures, breathing, and meditation to improve strength, reduce anxiety, and enhance overall well-being.

2. Tai chi
   A gentle martial art focusing on slow, controlled movements to improve balance, flexibility, and mental calmness.

3. Meditation and mindfulness
   Reduces stress and anxiety, improving emotional resilience during cancer management.

Educational and Self-Management Interventions

1. Pain education programs
   Teach patients how to understand and cope with cancer-related pain.

2. Self-care skill training
   Helps patients learn daily strategies for managing fatigue, diet, and symptoms.

3. Fatigue management education
   Offers practical advice on conserving energy and balancing activities.

Drugs (Evidence-Based)

1. Aspirin
   Class: NSAID.
   Dosage: 81–325 mg daily (for chemoprevention).
   Purpose: May reduce colorectal cancer risk.
   Side effects: Stomach irritation, bleeding risk.

2. 5-Fluorouracil (5-FU)
   Class: Antimetabolite chemotherapy.
   Dosage: Varies by regimen (e.g., continuous infusion or bolus).
   Purpose: Used in colorectal cancer treatment.
   Side effects: Mouth sores, diarrhea, low blood counts.

3. Capecitabine
   Class: Oral fluoropyrimidine.
   Dosage: Usually 1250 mg/m² twice daily for 14 days in a 21-day cycle.
   Purpose: Alternative to 5-FU.
   Side effects: Hand-foot syndrome, nausea.

4. Oxaliplatin
   Class: Platinum-based chemotherapy.
   Dosage: Typically 85 mg/m² every 2 weeks.
   Purpose: Combined with 5-FU for advanced disease.
   Side effects: Neuropathy, low blood counts.

5. Irinotecan
   Class: Topoisomerase inhibitor.
   Dosage: 180 mg/m² every 2 weeks.
   Purpose: Second-line colorectal cancer therapy.
   Side effects: Severe diarrhea, neutropenia.

6. Bevacizumab
   Class: Anti-VEGF antibody.
   Dosage: 5–10 mg/kg every 2 weeks.
   Purpose: Inhibits tumor blood vessel growth.
   Side effects: Hypertension, bleeding risk.

7. Cetuximab
   Class: EGFR inhibitor.
   Dosage: 400 mg/m² initial, then 250 mg/m² weekly.
   Purpose: For RAS wild-type tumors.
   Side effects: Skin rash, infusion reactions.

8. Pembrolizumab
   Class: PD-1 inhibitor immunotherapy.
   Dosage: 200 mg every 3 weeks.
   Purpose: For MMR-deficient tumors.
   Side effects: Fatigue, immune-related side effects.

9. Nivolumab
   Class: PD-1 inhibitor.
   Dosage: 240 mg every 2 weeks.
   Purpose: Similar to pembrolizumab.
   Side effects: Autoimmune reactions.

10. Lenvatinib
    Class: Multi-kinase inhibitor.
    Dosage: 20 mg daily.
    Purpose: For advanced endometrial cancer.
    Side effects: Hypertension, fatigue.

11. Tamoxifen
    Class: Estrogen receptor modulator.
    Dosage: 20 mg daily.
    Purpose: For patients with certain secondary breast cancers.
    Side effects: Hot flashes, clot risk.

12. Leucovorin
    Class: Folinic acid.
    Dosage: Varies with 5-FU regimens.
    Purpose: Enhances 5-FU effect.
    Side effects: Mild; enhances side effects of 5-FU.

13. Regorafenib
    Class: Multi-kinase inhibitor.
    Dosage: 160 mg daily for 21 days on/7 days off.
    Purpose: Advanced colorectal cancer.
    Side effects: Fatigue, liver toxicity.

14. Trifluridine/tipiracil
    Class: Antimetabolite combination.
    Dosage: 35 mg/m² twice daily, days 1-5 and 8-12 in a 28-day cycle.
    Purpose: Late-line colorectal cancer.
    Side effects: Low blood counts, nausea.

15. Ziv-aflibercept
    Class: VEGF trap.
    Dosage: 4 mg/kg every 2 weeks.
    Purpose: With FOLFIRI regimen.
    Side effects: Hypertension, bleeding.

16. Ramucirumab
    Class: VEGFR-2 inhibitor.
    Dosage: 8 mg/kg every 2 weeks.
    Purpose: Advanced cancers.
    Side effects: High blood pressure, proteinuria.

17. Panitumumab
    Class: EGFR inhibitor.
    Dosage: 6 mg/kg every 2 weeks.
    Purpose: Similar to cetuximab.
    Side effects: Skin toxicity.

18. Aflibercept
    Class: VEGF inhibitor.
    Dosage: 4 mg/kg every 2 weeks.
    Purpose: In combination chemotherapy.
    Side effects: Bleeding, clotting.

19. Aspirin high-dose
    Class: NSAID (higher dose).
    Dosage: Up to 600 mg daily (investigational for cancer prevention).
    Side effects: Gastrointestinal bleeding.

20. Lynch-specific vaccines (future research)
    Class: Immunotherapy.
    Dosage: Under investigation.
    Purpose: Potential to prevent tumors.
    Side effects: Not fully known yet.

Dietary Molecular Supplements

1. Vitamin D
   Dosage: 1,000–2,000 IU daily.
   Function: Supports immune function and may help reduce cancer risk.
   Mechanism: Regulates cell growth and immune modulation.

2. Calcium
   Dosage: 1,000–1,500 mg daily.
   Function: May lower colorectal cancer risk.
   Mechanism: Binds bile acids, reducing mucosal irritation.

3. Omega-3 fatty acids
   Dosage: 1,000–2,000 mg daily.
   Function: Reduces inflammation and supports heart health.
   Mechanism: Anti-inflammatory effects.

4. Curcumin
   Dosage: 500–1,000 mg daily.
   Function: Anti-inflammatory, potential cancer preventive.
   Mechanism: Modulates signaling pathways involved in cell proliferation.

5. Green tea extract (EGCG)
   Dosage: 300–500 mg daily.
   Function: Antioxidant, may reduce tumor growth.
   Mechanism: Inhibits DNA damage.

6. Folate
   Dosage: 400–800 mcg daily.
   Function: Supports DNA synthesis and repair.
   Mechanism: Essential in methylation processes.

7. Selenium
   Dosage: 100–200 mcg daily.
   Function: Antioxidant defense.
   Mechanism: Reduces oxidative stress.

8. Probiotics
   Dosage: 1–10 billion CFU daily.
   Function: Supports gut health and immunity.
   Mechanism: Modulates gut microbiota.

9. Resveratrol
   Dosage: 100–250 mg daily.
   Function: Anti-aging and anti-cancer properties.
   Mechanism: Inhibits cancer cell proliferation.

10. Fiber supplements
    Dosage: 20–30 g daily.
    Function: Promotes bowel health.
    Mechanism: Reduces transit time and dilutes carcinogens.

Additional Drug Therapies

Bisphosphonates

1. Alendronate
   Dosage: 70 mg weekly.
   Function: Strengthens bones, prevents metastasis-related fractures.
   Mechanism: Inhibits bone resorption.

2. Zoledronic acid
   Dosage: 4 mg IV every 3–4 weeks.
   Function: Reduces skeletal-related events.
   Mechanism: Strong osteoclast inhibition.

Regenerative and Stem Cell Drugs

3. Mesenchymal stem cells (experimental)
   Dosage: Varies in trials.
   Function: Tissue regeneration.
   Mechanism: Differentiates into multiple cell types.

4. Hematopoietic stem cells
   Dosage: Individualized.
   Function: Restores blood cells after intensive chemo.
   Mechanism: Replaces damaged marrow.

Viscosupplementations

5. Hyaluronic acid injections
   Dosage: Weekly for 3–5 weeks.
   Function: Joint lubrication.
   Mechanism: Improves synovial fluid quality.

6. Platelet-rich plasma (PRP)
   Dosage: Typically 1–3 injections.
   Function: Accelerates healing.
   Mechanism: Growth factor release.

7. Stem cell-conditioned media
   Dosage: Under research.
   Function: Promotes repair.
   Mechanism: Paracrine signaling.

Other Regenerative Drugs

8. Bone morphogenetic proteins
   Dosage: Local application in surgery.
   Function: Stimulates bone growth.
   Mechanism: Osteoinduction.

9. Synthetic peptide gels
   Dosage: Depends on application.
   Function: Promotes wound healing.
   Mechanism: Cellular migration support.

10. Growth factor concentrates
    Dosage: Localized application.
    Function: Tissue regeneration.
    Mechanism: Stimulates repair pathways.

Surgeries

1. Colectomy
   Procedure: Removes part or all of the colon.
   Benefits: Reduces colorectal cancer risk.

2. Prophylactic hysterectomy
   Procedure: Removes the uterus.
   Benefits: Prevents endometrial cancer.

3. Bilateral salpingo-oophorectomy
   Procedure: Removes ovaries and fallopian tubes.
   Benefits: Prevents ovarian cancer.

4. Polypectomy
   Procedure: Removes colon polyps during colonoscopy.
   Benefits: Prevents progression to cancer.

5. Segmental bowel resection
   Procedure: Removes cancerous bowel sections.
   Benefits: Cancer removal, preserves bowel function.

6. Liver metastasectomy
   Procedure: Removes liver metastases.
   Benefits: Improves survival.

7. Lymph node dissection
   Procedure: Removes regional lymph nodes.
   Benefits: Stages cancer and prevents spread.

8. Hepatic artery infusion pump placement
   Procedure: Delivers chemotherapy directly to liver.
   Benefits: Higher local drug concentration.

9. Pelvic exenteration
   Procedure: Removes pelvic organs in advanced cancer.
   Benefits: Last resort curative option.

10. Minimally invasive laparoscopic surgery
    Procedure: Uses small incisions and a camera.
    Benefits: Less pain, faster recovery.

Prevention Tips

1. Regular colonoscopy screenings
   Detect polyps early and remove them before cancer develops.

2. Genetic counseling
   Identify at-risk family members and plan surveillance.

3. Healthy diet
   Rich in vegetables, whole grains, and fiber reduces risk.

4. Regular physical activity
   Keeps weight healthy and reduces inflammation.

5. Avoid smoking
   Smoking increases various cancer risks.

6. Limit alcohol consumption
   Excess alcohol can promote cancer development.

7. Maintain a healthy weight
   Obesity is a known cancer risk factor.

8. Use of aspirin (under doctor advice)
   Reduces polyp formation.

9. Manage chronic conditions
   Diabetes and inflammatory bowel disease may elevate risk.

10. Regular gynecological exams
    Essential for women to detect endometrial changes early.

When to See a Doctor

Seek immediate medical advice if you have unexplained weight loss, blood in stool, persistent abdominal pain, prolonged fatigue, or changes in bowel habits. Early detection saves lives.

What to Do and What to Avoid

What to Do

1. Follow recommended screening schedules.

2. Eat a balanced diet.

3. Stay physically active.

4. Adhere to medical advice and medication.

5. Attend genetic counseling.

6. Monitor for new symptoms.

7. Maintain hydration.

8. Join support groups.

9. Use stress-reduction techniques.

10. Stay updated on new research.

What to Avoid

1. Ignoring family history.

2. Smoking.

3. Excessive alcohol.

4. Processed meats in large amounts.

5. Self-medicating.

6. Ignoring regular check-ups.

7. Sedentary lifestyle.

8. Crash dieting.

9. Overusing supplements without guidance.

10. Delaying medical care for new symptoms.

Frequently Asked Questions (FAQs)

1. What is mismatch repair cancer syndrome?
   It is a genetic condition that increases cancer risk due to defective DNA repair.

2. Is it the same as Lynch syndrome?
   Yes, Lynch syndrome is the most common type of MMR syndrome.

3. What cancers are most common?
   Colorectal and endometrial cancers.

4. How is it inherited?
   Autosomal dominant—one mutated gene from either parent.

5. Can it be prevented?
   While not fully preventable, regular screenings and surgeries reduce risk.

6. Is genetic testing necessary?
   Yes, especially if there’s a strong family history.

7. When should screening start?
   Often from age 20–25 or 2–5 years before the earliest family cancer.

8. What if I test positive?
   You’ll follow a personalized surveillance and prevention plan.

9. Are there lifestyle changes that help?
   Yes—healthy diet, exercise, and no smoking.

10. Is there a cure?
    No cure for the genetic mutation, but cancers can be treated or prevented.

11. What treatments are available?
    Surgery, chemotherapy, targeted drugs, immunotherapy.

12. Does insurance cover genetic testing?
    Often yes, depending on guidelines and risk.

13. Can men also get it?
    Yes, men can develop colorectal and other cancers.

14. Can I have children?
    Yes, but genetic counseling is advised.

15. Will I definitely get cancer?
    No, but your risk is significantly higher.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: July 04, 2025.